Envision Healthcare (EVHC) Reports In-Line Q3 EPS

Envision Healthcare (NYSE: EVHC) reported Q3 EPS of $0.36, in-line with the analyst estimate of $0.36. Revenue for the quarter came in at $1.64 billion versus the consensus estimate of $1.67 billion.

GUIDANCE:

Envision Healthcare sees FY2016 EPS of $1.39-$1.42, versus the consensus of $1.43.

• now expects to generate Adjusted EBITDA of $705 million to $715 million

For earnings history and earnings-related data on Envision Healthcare (EVHC) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform